Brovana: Long-Acting Relief for COPD Patients

A brand name for arformoterol, a long-acting beta agonist that helps improve breathing in individuals with chronic obstructive pulmonary disease (COPD).

Brovana FAQ

Image credit: goodrx.com

What are the side effects of Brovana?

hoarseness or deepened voice. Tell your doctor if you have serious side effects of Brovana including: increased thirst or urination.

How does Brovana work?

Brovana is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Brovana inhalation solution is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease ( COPD ), including chronic bronchitis and emphysema. Brovana will not treat a bronchospasm attack that has already begun.

Is Brovana a bronchodilator?

Brovana (arformoterol tartrate) Inhalation Solution is a bronchodilator used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease ( COPD ), including chronic bronchitis and emphysema. Brovana will not treat a bronchospasm attack that has already begun. What Are Side Effects of Brovana? hoarseness or deepened voice.

What is Brovana inhalation solution used for?

BROVANA Inhalation Solution is approved for use in the long-term maintenance treatment of bronchoconstriction associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. This disease does not occur in children.

Is Brovana a safe drug?

The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Brovana (arformoterol tartrate) is a drug used to treat chronic obstructive pulmonary disease (COPD). Brovana is inhaled using a jet nebulizer.

How is Brovana supplied?

16. How is Brovana supplied BROVANA (arformoterol tartrate) Inhalation Solution is supplied in a single strength (15 mcg of arformoterol, equivalent to 22 mcg of arformoterol tartrate) as 2 mL of a sterile solution in low-density polyethylene (LDPE) unit-dose vials overwrapped in foil.